Zhuoyi Bio
Zhuoyi Bio
Zhuoyi Bio

Step into Zhuoyi

Weekly Q&A | Which populations should receive pre-exposure prophylaxis?

Release Date:

2025-09-29

▲Click the image to view the answer▲




Previous Q&A Recommendations

Swipe left or right to see more





- About Zhuoyi Bio -


Zhuoyi uses human‑derived strains, ensuring greater efficacy with a shared origin; Zhuoyi employs Vero cells, offering enhanced safety by eliminating tumor‑forming risks; Zhuoyi features VVM labeling, providing visible assurance of safety and effectiveness; and Zhuoyi’s rabies vaccine is patented, with zero added antibiotics for added peace of mind.

Zhuoyi Biotechnology adheres to the philosophy of “Healthier, More Professional,” and is committed to becoming a global vaccine manufacturer that delivers superior quality, broad accessibility, and sustainable development, contributing Zhuoyi’s strength to Healthy China and the advancement of global public health.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home